(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SCALEPHARM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

SCALEPHARM

ST13

US500000079265052

Class

5, 39, 42, 44

Filing

79265052

Registration

5993308

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

25

Latest update

02/25/2025

Trademark type

Combined

Nice classes

5, 39, 42, 44

Filing date

06/19/2019

Registration date

02/25/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/25/2020

Last transaction

02/25/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

25

Owner location

CH

Examiner

STRUCK, ROBERT

Law office

L90

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized wording "SCALEPHARM" with "SCALE" in green and "PHARM" in blue and a design of a blue circle surrounded by four concentric ovals in gray. The color white represents background and transparent areas and is not a part of the mark.

Holders and representatives

Holders

SCALEPHARM AG

Representatives

Alexander Lazouski Lazouski IP LLC

Technical classification

Nice Classes

Class 5Class 39Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment and prevention of inflammatory and dermatological diseasescancerdiseases of the cardiovascular systemshormonal disordersdiseases of the nervous systeminfections and muscular disorders; medical and veterinary preparations for the treatment of inflammatory and dermatological diseasescancerdiseases of the cardiovascular systemshormonal disordersdiseases of the nervous systeminfections and muscular disorders; sanitary products for medical purposessanitary sterilizing preparations; dietetic food and beverages for medical or veterinary use

Class 39

Packaging and storage of merchandise for others; supply chain logistics and reverse logistics serviceswarehousing servicestransport and delivery of pharmaceutical products

Class 42

Technological advice relating to pharmaceutical preparations; conducting of scientific feasibility studies

Class 44

Advisory services relating to pharmaceutical products and preparations

Publications

History of USPTO decisions and trademark events.

25 publications found

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

02/25/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

03/09/2024

NREP

NEW REPRESENTATIVE AT IB RECEIVED

10/16/2020

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

07/10/2020

FICS

FINAL DISPOSITION NOTICE SENT TO IB

06/22/2020

FIMP

FINAL DISPOSITION PROCESSED

06/22/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

05/25/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

02/25/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/10/2019

PUBO

PUBLISHED FOR OPPOSITION

12/10/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/20/2019

ALIE

ASSIGNED TO LIE

11/05/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/31/2019

RFNT

REFUSAL PROCESSED BY IB

10/12/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/08/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/07/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/07/2019

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

09/26/2019

RFRR

REFUSAL PROCESSED BY MPU

09/26/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

09/18/2019

CNRT

NON-FINAL ACTION WRITTEN

09/17/2019

DOCK

ASSIGNED TO EXAMINER

09/10/2019

MAFR

APPLICATION FILING RECEIPT MAILED

08/27/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/21/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

08/15/2019

Continuous trademark protection

Get notified about every new filing that threatens SCALEPHARM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.